- Home
- FTRE vs DMLP Comparison
FTRE vs DMLP Comparison
Compare FTRE & DMLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- DMLP
- Stock Information
- Founded
- FTRE 1996
- DMLP 2003
- Country
- FTRE United States
- DMLP United States
- Employees
- FTRE N/A
- DMLP N/A
- Industry
- FTRE Medical Specialities
- DMLP Oil & Gas Production
- Sector
- FTRE Health Care
- DMLP Energy
- Exchange
- FTRE Nasdaq
- DMLP Nasdaq
- Market Cap
- FTRE 1.9B
- DMLP 1.6B
- IPO Year
- FTRE N/A
- DMLP N/A
- Fundamental
- Price
- FTRE $19.34
- DMLP $33.21
- Analyst Decision
- FTRE Hold
- DMLP
- Analyst Count
- FTRE 11
- DMLP 0
- Target Price
- FTRE $23.30
- DMLP N/A
- AVG Volume (30 Days)
- FTRE 1.2M
- DMLP 132.7K
- Earning Date
- FTRE 11-08-2024
- DMLP 10-31-2024
- Dividend Yield
- FTRE N/A
- DMLP 12.29%
- EPS Growth
- FTRE N/A
- DMLP 4.55
- EPS
- FTRE N/A
- DMLP 2.78
- Revenue
- FTRE $2,975,600,000.00
- DMLP $166,454,000.00
- Revenue This Year
- FTRE N/A
- DMLP N/A
- Revenue Next Year
- FTRE $1.23
- DMLP N/A
- P/E Ratio
- FTRE N/A
- DMLP $11.76
- Revenue Growth
- FTRE 2.80
- DMLP 14.26
- 52 Week Low
- FTRE $16.53
- DMLP $28.41
- 52 Week High
- FTRE $41.02
- DMLP $35.74
- Technical
- Relative Strength Index (RSI)
- FTRE 46.40
- DMLP 45.31
- Support Level
- FTRE $19.44
- DMLP $32.00
- Resistance Level
- FTRE $20.86
- DMLP $34.50
- Average True Range (ATR)
- FTRE 1.45
- DMLP 0.88
- MACD
- FTRE -0.29
- DMLP -0.16
- Stochastic Oscillator
- FTRE 13.39
- DMLP 25.66
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.